News

KTLA-TV interviewed Dr. Anne Rimoin, associate dean for global health and professor in the Department of Epidemiology, about the current outbreak in Central Africa.

Don’t be surprised if Dr. Robert Kim-Farley looks familiar from somewhere other than the classroom - he has also taken the stage as a singer and guitarist under the name “Gage.”

CNN interviewed Dr. Anne Rimoin, associate dean for global health and professor in the Department of Epidemiology, about the current measles outbreak in Pennsylvania.

NBC interviewed Dr. Anne Rimoin, professor in the Department of Epidemiology, about a suspected case of pneumonic plague in Russia.

The BBC interviewed Dr. Anne Rimoin, professor in the Department of Epidemiology and the Gordon–Levin Endowed Chair in Infectious Diseases and Public Health, about the ongoing Ebola outbreak in Central Africa, following an announcement by authorities that the death toll has surpassed 4,000.

The American Journal of Public Health (AJPH) published a commentary co-authored by UCLA Fielding’s Dr. Robert Kim-Farley, on a partnership between the AJPH and the American College of Obstetricians and Gynecologists to help disseminate a Maternal Immunization Schedule.

Research led by UCLA Fielding's Dr. Matthew Mimiaga will include analysis of the impact of the 2025 Los Angeles wildfires on those living with HIV, among other areas of study.

USA Today interviewed Dr. Anne Rimoin, professor in the Department of Epidemiology, about a rise in COVID-19 cases across the United States.

The UCLA Fielding School of Public Health is welcoming almost 500 new undergraduate and graduate students this fall.

Sukrity Ojha, a UCLA Fielding international student from Nepal in the MPH program and a “student ambassador” is working to support flood relief projects in the South Asian nation.

NPR (KCRW-FM) interviewed Dr. Anne Rimoin, associate dean of global health and professor in the Department of Epidemiology, about her research into Ebola vaccines, including newly-published work that suggests an existing vaccine could benefit patients in the current outbreak, the worst in the Democratic Republic of the Congo’s history.

A study led by the UCLA Fielding School of Public Health and the DRC’s National Institute of Biomedical Research, published in The Lancet, provides new human evidence supporting clinical evaluation of an already-licensed Ebola vaccine against the virus driving the ongoing Bundibugyo outbreak.